Literature DB >> 22208532

Dynamics and hydration of the active sites of mammalian cytochromes P450 probed by molecular dynamics simulations.

Tereza Hendrychova1, Karel Berka, Veronika Navratilova, Pavel Anzenbacher, Michal Otyepka.   

Abstract

The flexibility, active site volume, solvation, and access path dynamics of six metabolically active mammalian cytochromes P450 (human 2A6, 2C9, 2D6, 2E1, 3A4 and rabbit 2B4) are extensively studied using molecular dynamics (MD) simulations. On average, the enzymes' overall structures equilibrate on a 50+ ns timescale. The very open CYP2B4 structure closes slowly over the course of the simulation. The volumes of the active sites fluctuate by more than 50% during the MD runs; these fluctuations are mainly due to movements of the main chains, with only a handful of amino acid residues in CYP2B4, CYP2D6, CYP2A6 and CYP2C9 showing significant independent side chain movement. The volume of the active site of CYP2E1 fluctuates heavily, ranging from 220 to 1310 A(3), due to the opening and closing of gates to two adjacent cavities. CYP2E1 has the least hydrated active site of the studied CYPs; this is consistent with its preference for non-polar substrates. The CYP2A6 and CYP2E1 active sites are deeply buried, with access paths that are narrower than the radius of a water molecule. However, waters are still able to access these active sites due to local adaptations of the channel to accommodate their passage. This finding may imply that the access paths of the CYPs never fully open prior to contact with the substrate; instead, the substrate may induce adaptive conformational changes during its passage to the active site. This may also explain why some substrate recognition sites are localized along individual enzymes' access paths.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22208532     DOI: 10.2174/138920012798918408

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  20 in total

Review 1.  Predicting drug metabolism: experiment and/or computation?

Authors:  Johannes Kirchmair; Andreas H Göller; Dieter Lang; Jens Kunze; Bernard Testa; Ian D Wilson; Robert C Glen; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2015-04-24       Impact factor: 84.694

2.  Inhibition of human cytochrome P450 2E1 and 2A6 by aldehydes: structure and activity relationships.

Authors:  Suneel K Kandagatla; Todd Mack; Sean Simpson; Jill Sollenberger; Eric Helton; Gregory M Raner
Journal:  Chem Biol Interact       Date:  2014-06-09       Impact factor: 5.192

3.  P450cin active site water: implications for substrate binding and solvent accessibility.

Authors:  Yarrow Madrona; Scott A Hollingsworth; Bushra Khan; Thomas L Poulos
Journal:  Biochemistry       Date:  2013-07-18       Impact factor: 3.162

4.  Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations.

Authors:  Joseph W Levy; Jessica H Hartman; Martin D Perry; Grover P Miller
Journal:  J Mol Graph Model       Date:  2014-12-06       Impact factor: 2.518

5.  Dynamics of CYP51: implications for function and inhibitor design.

Authors:  Xiaofeng Yu; Vlad Cojocaru; Ghulam Mustafa; Outi M H Salo-Ahen; Galina I Lepesheva; Rebecca C Wade
Journal:  J Mol Recognit       Date:  2015-01-20       Impact factor: 2.137

6.  Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules.

Authors:  Manish B Shah; P Ross Wilderman; Jaime Pascual; Qinghai Zhang; C David Stout; James R Halpert
Journal:  Biochemistry       Date:  2012-09-04       Impact factor: 3.162

7.  Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5).

Authors:  Chunsheng Zhao; Qiuxia Gao; Arthur G Roberts; Scott A Shaffer; Catalin E Doneanu; Song Xue; David R Goodlett; Sidney D Nelson; William M Atkins
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

8.  Ligand tunnels in T. brucei and human CYP51: Insights for parasite-specific drug design.

Authors:  Xiaofeng Yu; Prajwal Nandekar; Ghulam Mustafa; Vlad Cojocaru; Galina I Lepesheva; Rebecca C Wade
Journal:  Biochim Biophys Acta       Date:  2015-10-19

9.  Uncovering of cytochrome P450 anatomy by SecStrAnnotator.

Authors:  Adam Midlik; Veronika Navrátilová; Taraka Ramji Moturu; Jaroslav Koča; Radka Svobodová; Karel Berka
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

10.  Multiscale Simulations on the Catalytic Plasticity of CYP76AH1.

Authors:  Yufan Qiu; Hongjuan Diao; Ying Zheng; Ruibo Wu
Journal:  Front Chem       Date:  2021-06-02       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.